The 2016 American Association of Clinical Endocrinologists/American College of Endocrinology Guidelines for postmenopausal osteoporosis provides comprehensive guidance on the diagnosis, evaluation and treatment of postmenopausal osteoporosis. A new diagnostic criterion which expands the diagnosis to patients with osteopenia and a high Fracture Risk Assessment Tool score has been added to the old diagnostic criteria. Recommendations on duration of bisphosphonate therapy are clearly outlined and are based on fracture risk stratification. The accompanying algorithm, which goes through all the steps from diagnosis to treatment and follow up is a handy guide for clinicians.
CITATION STYLE
Camacho, P. M. (2016). 2016 American Association of Clinical Endocrinologists/ American College of Endocrinology clinical practice guidelines on postmenopausal osteoporosis. US Endocrinology. Touch Briefings. https://doi.org/10.17925/USE.2016.12.02.74
Mendeley helps you to discover research relevant for your work.